2021 - 2024 Development of therapeutic strategy by eliminating mutant mitochondria for mitochondrial diseases
2020 - 2022 Development of anticancer drugs targeting the mutated cancer genome
2020 - 2021 Design, development and validation of ultra-sensitive detection platform for rare somatic genomic aberrations
2017 - 2020 Analyzing Genomic Binding of Pyrrole-Imidazole Polyamides by Machine Learning
Show all
Papers (32):
Hideki Ikeda, Katsushige Kawase, Tatsuya Nishi, Tomofumi Watanabe, Keizo Takenaga, Takashi Inozume, Takamasa Ishino, Sho Aki, Jason Lin, Shusuke Kawashima, et al. Publisher Correction: Immune evasion through mitochondrial transfer in the tumour microenvironment. Nature. 2025. 639. 8053. E5
Hideki Ikeda, Katsushige Kawase, Tatsuya Nishi, Tomofumi Watanabe, Keizo Takenaga, Takashi Inozume, Takamasa Ishino, Sho Aki, Jason Lin, Shusuke Kawashima, et al. Immune evasion through mitochondrial transfer in the tumour microenvironment. Nature. 2025
Jihang Yao, Keizo Takenaga, Nobuko Koshikawa, Yuki Kida, Jason Lin, Takayoshi Watanabe, Yoshiaki Maru, Yoshitaka Hippo, Seigi Yamamoto, Yuyan Zhu, et al. Anticancer effect of a pyrrole-imidazole polyamide-triphenylphosphonium conjugate selectively targeting a common mitochondrial DNA cancer risk variant in cervical cancer cells. International Journal of Cancer. 2023. 152. 5. 962-976
Jason Lin, Shang-Chuen Wu. Implications of Transglutaminase-Mediated Protein Serotonylation in the Epigenetic Landscape, Small Cell Lung Cancer, and Beyond. Cancers. 2023. 15. 4. 1332-1332
Akiko Tsujimoto, Niina Matsuo, Xiaoyi Lai, Takahiro Inoue, Hiroyuki Yoda, Jason Lin, Yoshinao Shinozaki, Takayoshi Watanabe, Nobuko Koshikawa, Atsushi Takatori, et al. Use of DNA-alkylating pyrrole-imidazole polyamides for anti-cancer drug sensitivity screening in pancreatic ductal adenocarcinoma. Cancer Medicine. 2022. 12. 5. 5821-5832